SECsense Logo

Trisalus Life Sciences, Inc. 8-K Report: Key Insights & Stock Update

$TLSI
Form 8-K
Filed on: 2025-02-19
Source
Trisalus Life Sciences, Inc. 8-K Report: Key Insights & Stock Update

Here are the key insights extracted from the provided section of the financial report for Trisalus Life Sciences, Inc. (CIK: 0001826667):

  1. Company Identification:
  • Name: Trisalus Life Sciences, Inc.
  • Location: 6272 W 91st Ave, Westminster, CO 80031
  • Contact: (888) 321-5212
  • SEC CIK: 0001826667
  • Filing Type: 8-K
  • SEC File Number: 001-39813
  • EIN: 85-3009869
  1. Filing Date:
  • The report is dated February 18, 2025.
  1. Stock Information:
  • Common Stock:
    • Par Value: $0.0001
    • Ticker Symbol: TLSI
    • Exchange: NASDAQ
  • Warrants:
    • Each whole warrant is exercisable for one share of common stock.
    • Exercise Price: $11.50 per share.
    • Ticker Symbol: TLSIW
    • Exchange: NASDAQ
  1. Segment Information:
  • The report mentions two classes of stock:
    • Common Stock
    • Warrants
  1. Context and Period:
  • All information is specific to the reporting period starting and ending on February 18, 2025.

Summary:

Trisalus Life Sciences, Inc. is a publicly traded company on NASDAQ, with its common stock and warrants listed under the symbols TLSI and TLSIW, respectively. The warrants provide an exercise option for purchasing shares at $11.50 each. The report is filed as an 8-K, which typically indicates a significant event or information that shareholders should be aware of. The filing date is February 18, 2025, which is crucial for understanding the timing of the reported information.